TY - JOUR
T1 - Enhancing the oral bioavailability of fisetin
T2 - polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery
AU - Gunjal, Pradnya
AU - Vishwas, Sukriti
AU - Kumar, Rajan
AU - Bashir, Bushra
AU - Kumar, Bimlesh
AU - Khurana, Navneet
AU - Gulati, Monica
AU - Gupta, Gaurav
AU - Prasher, Parteek
AU - Kumbhar, Popat
AU - Disouza, John
AU - Kuppusamy, Gowthamarajan
AU - Mohammed, Yousuf
AU - Dureja, Harish
AU - Dua, Kamal
AU - Singh, Sachin Kumar
N1 - Publisher Copyright:
© Controlled Release Society 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
PY - 2024/10
Y1 - 2024/10
N2 - Fisetin (FS) is a flavonoid that possesses antioxidant andanti-inflammatory properties against ulcerative colitis. FS shows poor dissolutionrate and permeability. An attempt has been made to develop colon-targeted solidself-nanoemulsifying drug delivery systems (S-SNEDDS) of FS. Initially, liquid (L)SNEDDS were prepared by loading FS into isotropic mixture of L-SNEDDS was preparedusing Labrafil M 1944 CS, Transcutol P, and Tween 80. These L-SNEDDS were furtherconverted into solid (S) SNEDDS by mixing the isotropic mixture with 1:1:1 ratio ofguar gum (GG), xanthan gum (XG) and pectin (PC) [GG:XG:PC (1:1:1)]. Aerosil-200(A-200) was added to enhance their flow characteristics. Further, they wereconverted into spheroids by extrusion-spheronization technique. The solid-statecharacterization of S-SNEDDS was done by SEM, DSC, and PXRD, which revealed that thecrystalline form of FS was converted into the amorphous form. In the dissolutionstudy, S-SNEDDS spheroids [GG:XG:PC (1:1:1)] exhibited less than 20% drug releasewithin the first 5 h, followed by rapid release of the drug between the 5th and 10thh, indicating its release at colonic site. The site-specific delivery of FS to colonvia FS-S-SNEDDS spheroids was confirmed by conducting pharmacokinetic studies onrats. Wherein, results showed delay in absorption of FS loaded in spheroids up to 5h and achievement of Cmax at 7h, whereas L-SNEDDS showed rapid absorption of FS.Furthermore, FS-L-SNEDDS and FS-S-SNEDDS spheroids [GG:XG:PC (1:1:1)] increased oralbioavailability of FS by 6.86-fold and 4.44-fold, respectively, as compared tounprocessed FS. Graphical Abstract: (Figure presented.)
AB - Fisetin (FS) is a flavonoid that possesses antioxidant andanti-inflammatory properties against ulcerative colitis. FS shows poor dissolutionrate and permeability. An attempt has been made to develop colon-targeted solidself-nanoemulsifying drug delivery systems (S-SNEDDS) of FS. Initially, liquid (L)SNEDDS were prepared by loading FS into isotropic mixture of L-SNEDDS was preparedusing Labrafil M 1944 CS, Transcutol P, and Tween 80. These L-SNEDDS were furtherconverted into solid (S) SNEDDS by mixing the isotropic mixture with 1:1:1 ratio ofguar gum (GG), xanthan gum (XG) and pectin (PC) [GG:XG:PC (1:1:1)]. Aerosil-200(A-200) was added to enhance their flow characteristics. Further, they wereconverted into spheroids by extrusion-spheronization technique. The solid-statecharacterization of S-SNEDDS was done by SEM, DSC, and PXRD, which revealed that thecrystalline form of FS was converted into the amorphous form. In the dissolutionstudy, S-SNEDDS spheroids [GG:XG:PC (1:1:1)] exhibited less than 20% drug releasewithin the first 5 h, followed by rapid release of the drug between the 5th and 10thh, indicating its release at colonic site. The site-specific delivery of FS to colonvia FS-S-SNEDDS spheroids was confirmed by conducting pharmacokinetic studies onrats. Wherein, results showed delay in absorption of FS loaded in spheroids up to 5h and achievement of Cmax at 7h, whereas L-SNEDDS showed rapid absorption of FS.Furthermore, FS-L-SNEDDS and FS-S-SNEDDS spheroids [GG:XG:PC (1:1:1)] increased oralbioavailability of FS by 6.86-fold and 4.44-fold, respectively, as compared tounprocessed FS. Graphical Abstract: (Figure presented.)
KW - Colon targeting
KW - Fisetin
KW - Pharmacokinetics
KW - Polysaccharides
KW - Self-nanoemulsifying drug delivery system
KW - Spheroids
UR - https://www.scopus.com/pages/publications/85194258854
U2 - 10.1007/s13346-024-01634-6
DO - 10.1007/s13346-024-01634-6
M3 - Article
C2 - 38789909
AN - SCOPUS:85194258854
SN - 2190-393X
VL - 14
SP - 1
EP - 17
JO - Drug Delivery and Translational Research
JF - Drug Delivery and Translational Research
IS - 10
ER -